Drug Pipeline

Pralatrexate Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
5
Active Studies
3
Recruiting
1
Phase 3
4
Top Sponsors
Active Studies by Phase
Phase 3
1
Phase 2
1
Phase 1/2
2
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06561048 Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral… Peripheral T-Cell Lymphoma, Not Otherwise Specified Recruiting
Phase 2
NCT04747236 Randomized Phase IIB Trial of Oral Azacytidine Plus Romidepsin Versus Investigator's… PTCL Recruiting
Phase 1/2
NCT07225985 Pralatrexate With Bendamustine and Total-Body Irradiation Followed by Donor Stem Cell… Recurrent T-Cell Non-Hodgkin Lymphoma Recruiting
NCT03598998 Pembrolizumab and Pralatrexate in Treating Patients With Relapsed or Refractory… Anaplastic Large Cell Lymphoma Active, Not Recruiting
Phase 1
NCT03240211 Study of Pembrolizumab Combined With Decitabine and Pralatrexate in PTCL and CTCL PTCL Active, Not Recruiting
Sponsors Running Pralatrexate Trials
University of Virginia (2) City of Hope Medical Center (1) Corvus Pharmaceuticals, Inc. (1) Fred Hutchinson Cancer Center (1)
Disease Areas
Non-Hodgkin Lymphoma (2) Follicular Lymphoma (1)
Get alerts when Pralatrexate trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free